AI assistant
Sending…
Gentian Diagnostics ASA — Director's Dealing 2023
Nov 24, 2023
3604_dirs_2023-11-24_a25a6eff-454b-492d-abe1-730d780c9c00.pdf
Director's Dealing
Open in viewerOpens in your device viewer
1 Details of the person discharging managerial responsibilities/person closely associated a) Name Njaal Kind 2 Reason for the notification a) Position/status CFO b) Initial notification/ Amendment Initial notification 3 Details of the issuer a) Name Gentian Diagnostics ASA b) LEI 5967007LIEEXZXHNM861 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. N/A b) Nature of the transaction Allocation of options c) Price(s) and volume(s) Price(s) Volume(s) 0 40,000 d) Aggregated information - Aggregated volume - Price 40,000 0 e) Date of the transaction 2023-11-23, 16:00 CET f) Place of the transaction XOFF - Outside of trading venue
Notification and public disclosure of transactions by Primary Insiders and their Close Associates
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Hilja Ibert | |||
| 2 | Reason for the notification | ||||
| c) | Position/status | CEO | |||
| d) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| c) | Name | Gentian Diagnostics ASA | |||
| d) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. |
|||
| Identification code | N/A | ||||
| b) | Nature of the transaction | Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 139,962 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
139,962 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated |
||||
|---|---|---|---|---|---|
| a) | Name | Torsten Knüttel | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Vice President R&D | |||
| b) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| a) | Name | Gentian Diagnostics ASA | |||
| b) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. |
|||
| Identification code | N/A | ||||
| b) | Nature of the transaction |
Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 30,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
30,000 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Aleksandra Havelka | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Scientific Officer | |||
| b) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| a) | Name | Gentian Diagnostics ASA | |||
| b) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument Identification code |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. N/A |
|||
| b) | Nature of the transaction | Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 30,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
30,000 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | Markus Jaquemar | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Vice President Sales and Marketing | ||||
| b) | Initial notification/ | Initial notification | ||||
| Amendment | ||||||
| 3 | Details of the issuer | |||||
| a) | Name | Gentian Diagnostics ASA | ||||
| b) | LEI | 5967007LIEEXZXHNM861 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) | Description of the financial instrument, type of instrument Identification code |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. N/A |
||||
| b) | Nature of the transaction | Allocation of options | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| 0 | 40,000 | |||||
| d) | Aggregated information | |||||
| - Aggregated volume |
40,000 | |||||
| - Price |
0 | |||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | ||||
| f) | Place of the transaction | XOFF - Outside of trading venue |
More from Gentian Diagnostics ASA
Major Shareholding Notification
2026
May 13
Director's Dealing
2026
May 13
Major Shareholding Notification
2026
May 13
Director's Dealing
2026
May 13
Major Shareholding Notification
2026
May 13
Board/Management Information
2026
May 13
Interim / Quarterly Report
2026
May 6
Interim / Quarterly Report
2026
May 6
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6